ArticleBMC pregnancy and childbirth2026
Characteristics of occult hepatitis B infection among pregnant women in the Center Region of Cameroon: rationale for universal administration of hepatitis B birth dose vaccine.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Diversity, Occult Hepatitis B, and Mutational Signatures in Migrants from Regions with Varying HBV Endemicity: Importation of Diverse Viral Variants into St. Petersburg, Russia.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOccult hepatitis B infection (OBI) among pregnant women poses a significant public health problem in the prevention of vertical transmission. A seroprevalence of overt hepatitis B among pregnant women in the Centre Region of Cameroon of 6.8% was reported. Although data on OBI is scarce among pregnant women in Cameroon, 5.5% was reported in AIDS patients in the Centre Region. The aim of this study was to determine hepatitis B virus (HBV) molecular and serological characteristics in OBI among pregnant women and to inform and guide policy makers in the development of prevention strategies of vertical transmission of HBV. MATERIALS AND
methodsA cross-sectional, descriptive study was conducted from January 2022 to July 2024 among pregnant women attending antenatal care centers in seven health facilities in the Centre Region of Cameroon. Venous blood was collected from women who gave written informed consent, and tested for HBsAg and anti-HIV antibodies using rapid tests and ELISA. Samples that were negative for HBsAg were further tested for HBeAg, anti-HBs and anti-HBc antibodies using ELISA. Plasma HBV DNA presence was detected and measured by nested PCR and real-time PCR, respectively, while HBV Sanger sequencing was performed on the HBV S gene, and a phylogenetic analysis using the MEGA software.
resultsOf 2033 HBsAg-negatives, HBV-DNA was tested in 249 (75 HIV-infected and 174 HIV-negative selected randomly). The rate of 3 dose hepatitis B vaccination in the study population was 7.2% (18/249). Of the 75 HIV-positive cases, 9.6% (24/75) and 12.1% (30/75) were positive for anti-HBs and anti-HBc antibodies, respectively. HBV-DNA was detected in 3.6% (9/249) and these were not vaccinated. The prevalence in the nine OBI cases were 77.8% (7/9), 55.6% (5/9), and 22.2% (2/9) for anti-HBc, anti-HBs, and anti-HBe antibodies, respectively. HBV genotypes A and E were identified in 2 cases each, and sY100C and sM125T mutations in 3 of the 4 cases.
conclusionThe prevalence of OBI among pregnant women highlights the need to promote hepatitis B birth dose vaccination for all newborn and not only for the exposed, as in the case of some African countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.